DavidESeitzMD

Addiction Medicine

Physician

Dr. Seitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Zucker School of Medicine at Hofstra/Northwell at South Shore University HospitalResidency, Family Medicine, 1988 - 1991
Stony Brook University Health Sciences Center School of MedicineClass of 1988

PubMed

34 citations
Phase II Study of Gemcitabine plus Docetaxel in Advanced Pancreatic Cancer: A Hoosier Oncology Group Study
Bryan P. Schneider, Kristen N. Ganjoo, David E. Seitz, Joel Picus, Farid Fata, Cindy Stoner, C. Calley, Patrick J. Loehrer> ;Oncology. 2003 Dec 1
1 citations
Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer.
George Wilding, Gerald B. Grindey, Nikhil C. Munshi, David E. Seitz, Lawrence H. Einhorn> ;Investigational New Drugs. 1993 Jun 1
12 citations
Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer.
Nikhil C. Munshi, David E. Seitz, Frank V. Fossella, Scott M. Lippman, Lawrence H. Einhorn> ;Investigational New Drugs. 1993 Feb 1
8 citations
Antitumor Activity and Clinical Pharmacology of Sulofenur in Ovarian Cancer
Charles W. Taylor, Yei Mei Peng, Thomas M. McCloskey, Monika Matzner, Denise J. Roe, Patricia M. Plezia, Gerald B. Grindey, Marta Hamilton, David E. Seitz, David S. Al...> ;Journal of the National Cancer Institute. 1992 Dec 2
2 citations
Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.
Frank V. Fossella, Scott M. Lippman, David E. Seitz, Charles W. Taylor, Eve Wiltshaw, Janet Hardy, Mary O'Brien, Thomas R. Haynes, Robert L. Wolen, David S. Alberts> ;Investigational New Drugs. 1991 Nov 1
Join now to see all

Smoking Shrinks the Brain and Increases the Risk of Alzheimer’s Disease, New Study FindsJanuary 4th, 2024
Smoking Shrinks the Brain and Drives up Alzheimer’s Risk, New Study FindsJanuary 6th, 2024